TIBSOVO (ivosidenib tablets): First-in-Class Targeted Inhibitor of mIDH1 in Previously Treated, Locally Advanced or Metastatic Cholangiocarcinoma (CCA)

Event Date:

Apr 29, 2026

Credit Type:

--

Credits:

--